October 2017

• Dr. Francis Price to Receive Thomas C. Hasbrook Award at Luncheon on Nov. 2, 2017

  

  Bosma Enterprises, an Indianapolis-based nonprofit organization dedicated to creating opportunities for Hoosiers who are blind or visually impaired, is set to honor Dr. Francis Price at its annual Hasbrook Awards Luncheon at The Crane Bay in Indianapolis.

  View Full Article Share

• Advancements in Cell Regeneration Not Yet as Reliable as DMEK

  

  Interest is now building to eliminate transplants altogether and allow a person's own endothelial cells to regenerate in a procedure called Descemet's Stripping without Endothelial Replacement. This article, written by Dr. Francis Price and Dr. Matthew Feng share their results on this newer procedure.

  View Full Article Share

• CRFA Announces New Rock Inhibitor Study

  

  The Cornea Research Foundation of America is pleased to announce a new investigational study, “The ROCK Inhibitor Study to Reduce Cornea Transplant Complications”. This study will enroll patients with Fuchs’ dystrophy or other forms of corneal endothelial failure who are undergoing a DMEK cornea transplant with Price Vision Group. The study aligns with the Foundation’s pioneering series of studies that began in 2011 to reduce side effects of corticosteroid eye drops to protect transplant health.

  View Full Article Share

• DMEK and the Influenza (Flu) Vaccine

  

  New research shows DMEK cornea transplant recipients do not need to adjust corticosteriod dosing prior to or after influenza vaccine. Read this article for up-to-date information regarding steroid use and vaccines with DMEK.

  View Full Article Share

• 1